Clinical Trial Update: Dipeptidyl Peptidase 4 Inhibition Facilitate Healing of Diabetic Ulcers [Phase 4]

View source ↗

Summary

This entry notes a Phase 4 clinical trial investigating dipeptidyl peptidase-4 inhibition as a strategy to heal diabetic foot ulcers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• DPP-4 inhibitor

Snippet

Sponsor: Long Min,MD | Conditions: Diabetic Foot Ulcer | Phase 4 | Status: UNKNOWN